Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Johns Hopkins Medicine researchers say they have found that levels of a specific protein appears to help accurately predict whether people with the wet form of age-related macular degeneration may need lifelong, frequent eye injections to preserve vision.
New findings about how the brain interprets sensory information may have applications for treating brain disorders and designing artificial intelligence.
The size of our primary visual cortex and the amount of brain tissue we have dedicated to processing visual information can predict how well we can see, a new study shows.
New research from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine is shining a light on whether vision screenings for older drivers identify those who are likely to have motor vehicle collisions in the next few years.
Researchers from the National Eye Institute (NEI) have identified a new disease that affects the macula, a small part of the light-sensing retina needed for sharp, central vision.
The AREDS2 formula not only reduces risk of lung cancer due to beta-carotene, but is also more effective at reducing risk of AMD progression, compared to the original formula.
A 28-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy (LHON) found no significant safety concerns; however, treatment failed to improve or slow vision loss, with even the highest dose.
